In particular, the present invention identifies melanoma cell adhesion molecule (MCAM) as a new type of serum tumour marker of YAP-dependent liver cancer. Also provided in the present invention are uses of the gene, mRNA or cDNA of the melanoma cell adhesion molecule (MCAM) as a marker for...
NOVEL LIVER CANCER MARKERIt becomes possible to diagnose whether or not a patient having a chronic liver disease is affected by liver cancer, by measuring the blood HDGF level in the patient. Also provided is a measurement kit for use in the diagnosis.MURATA, KAORI...
cancer protein marker for the liver cell cancer detection which consists of method, and the said protein which decide the liver cell cancer making use of the protein where phosphorylation decoration state differs in the liver cell cancer cell in comparison with the non liver cancer cell is ...
Su et al., found that expression of known oncomarker of HCC, gankyrin, is promoted by IL-1b/IRAK-1 signaling through JNK and NF-Y/p300/CBP complex. Upregulation of gankirin can be blocked by respective IRAK-1 and JNK inhibitors. This work shows link between gankyrin, hepatic inflammation...
Hepatocellular carcinoma is the fifth most common cancer worlwide. Validated markers for liver cancer will improve early HCC detection.
Specifically, the marker is LINC00511. According to the biological marker, a condition that differential expression of the LINC00511 is related with occurrence and development of the liver cancer is found for the first time; in patients with the liver cancer, expression of the LINC00511 is ...
Cancer of the liver is very difficult to detect, and it is a major cause of death in Asia and Africa, with rising incidence in Western countries as well. Now, VIB researchers connected to Ghent University, in collaboration with research centers in Beijin
M. et al. REporting recommendations for tumour MARKer prognostic studies (REMARK). Br. J. Cancer 93, 387–391 (2005). Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68, 394–...
Liver cancer is a major cause of morbidity and mortality in the world. The primary goals of this manuscript are the identification of novel imaging markers (morphological, functional, and anatomical/textural), and development of a computer-aided diagnostic (CAD) system to accurately detect and grad...
Being a serum marker, FT has the advantage of representing a more global estimate of liver fibrosis throughout the whole liver. One case was emblematic of the weakness of even a 20 mm-long biopsy: a patient had severe fibrosis (F3) on the first biopsy, no fibrosis on the second biopsy ...